SOLASTA Bio secures patent and EPA approval

An agri-biotech firm says it has taken “one giant stride” in its route to market with major regulatory and intellectual property wins.

SOLASTA Bio, which develops nature-inspired bioinsecticides, has secured its first patent grant, reinforcing its technology for pest control using insect neuropeptides. 

The Glasgow-based company has also received a crucial classification from the US Environmental Protection Agency, streamlining its regulatory path. 

The milestones follow a $14 million funding round last year, with bosses saying they will help position SOLASTA Bio “exceptionally well” as it looks to commercialise its eco-friendly insecticides.

Shireen Davies, SOLASTA Bio co-founder and chief executive, said: “These developments represent a major inflection point. 

“The combination of strong patent protection and a more efficient regulatory pathway positions us exceptionally well to advance our product development and reach full commercialisation within a few years. 

“Our technology has the potential to transform the global crop protection market, and we are now one giant stride closer to realising that vision.”

Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →

Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.